Researchers at the Vall d’Hebron Institute of Oncology (VHIO) have had a prominent presence at the annual congress of the European Society for Medical Oncology (ESMO), which is being held in Paris from September 9 until today. Thus, the VHIO has played a leading role in several trials advancing new treatment options in metastatic colorectal […]